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ABSTRACT
Facing the danger of Gram-positive bacterial infection, mammalian cells have their defense line.
A functional proteomics study aided with Deep Learning indicates the direct interaction between
collagen V from mammalian cell membrane and Sortase A which catalyzes the display of
virulence factors on the gram positive bacteria. And CHO cell proteomes conducted with the use
artificial intelligence via Tensorflow and found that the identified anti collagen V binds to
Sortase A of S. aureus and regulates its monomer-homodimer equilibrium, which is responsible
for the bacterial cell wall sorting activity. Our results suggest that the collagen V plays an
instrumental role in inhibiting Gram-positive bacterial infections and impeding their
pathogenicity.
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Chapter 1. Introduction
1.1:Background
Methicillin-resistant staphylococcus aureus, for instance, known as MRSA, is a type of
Gram-positive bacteria commonly spread in healthcare facilities and the community, and it is
extremely difficult to treat due to resistance to many first-line antibiotics, such as methicillin,
amoxicillin, and penicillin1, 2.Despite the overall infection cases are gradually dropping,
progress in preventing MRSA infections and options for treating them is rapidly slowing and
limiting, respectively [1, 2]. In 2017, there were an estimated 323,700 MRSA infections cases,
resulting in 10,600 deaths, resulting in approximately $1.7 billion in medical expenses for one
type of infection alone[2].Due to the antibiotic-resistant nature to multiple existing drugs that
target certain cellular components, alternative therapeutics that target a different part of the
bacterial cell have to be developed. Anti-virulence strategies to combat bacterial infection
represent an attractive approach in treating bacteria-mediated diseases[3].By interfering with the
expression and biological functions of certain disease-causing virulence traits, the bacteria are
less able to colonize,invade, and persist in the host cells. Instead of killing the pathogens by
conferring mutant strains with a strong selective advantage, reduced survival pressure imposed
by alternative anti-virulence strategies can render a slower rate of and less frequent development
of clinically relevant resistant strains toward the corresponding antivirulence agents[4].
Virulence factors are specialized molecules, cellular structures, and regulatory systems that
are utilized by microorganisms in invading the host and causing corresponding diseases[4, 5].
For example, several independent microbial surface components,such as fibronectin-binding
protein A and B (FnBPA and FnBPB), clumping factor A and B (ClfA and ClfB), and collagen
adhesin (Cna), that bind to extracellular matrix (ECM) proteins also play some essential roles in
the later stage of biofilm formation and infection. In general, the production of virulence factors,
such as pili and secretion systems, is metabolically expensive, and as a result, their expression is
tightly regulated4. Once inside suitable hosts, their ability to sense environmental stimuli enable
the bacteria to activate specific virulence traits that are needed for infection[6, 7]. In addition,
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proper folding and molecular assembly of the virulence factors are essential for their biological
activities[8].
1.2: Sortase A
In Gram-positive bacteria, including methicillin-resistant staphylococcus aureus, many bacterial
proteins displayed on the surface are transferred and anchored on the cell surface using sortase
(Srt) enzymes. Sortase A is a protein that is expressed on gram-positive bacteria, which is one of
the most common enzymes. The LPXT Gmotif is part of the sorting signal that will be first
cleaved by the Sortase A, and the resulting surface protein intermediate is the covalently attached
to the cell wall, a characteristic structure of Gram-positive bacteria, displaying the protein on the
microbial surface as a consequence[9, 10]. Since Sortase A is a type of transpeptidase enzyme
only found in bacteria, potential therapeutics can be developed specifically targeting Sortase
A-associated signaling pathways without a negative impact on the host cells. By developing
antibodies that either target Sortase A or associated signal pathways, bacterial infection can be
inhibited sinceno virulence factors are produced to initiate the corresponding infection process.
Recent studies of virulence of S.aureus infections have been associated with the identification of
the numerous virulence factors such as styes, furunculosis, and paronychia, or to more serious
infections, such as pneumonia, mastitis, urinary tract infections, osteomyelitis, endocarditis, and
even sepsis[39,40] in which the pathways for pathogenesis are downstream processes that often
require multiple targets of inhibition for therapeutic applications. However, while the current
studies of virulence factors of S.aureas have identified various virulence factors, there remains
much of individual virulence factor mechanisms that have yet to be discovered. Thus, the
significance of identifying the messenger molecule in the upstream pathogenic infection can pose
an alternative solution for therapeutic application by direct inhibition of sortase A \emph{in
vivo}. This makes sense established upon different virulence factors through different molecules,
sortase A stops at infection upstream.
1.2.1:Monomer-homodimer Equilibrium
In contrast to many other bacterial infections,of which the corresponding diseases are often
caused by only one or a few virulence factors, various adhesins, toxins, and specialized secretion
systems have been utilized by S. aureus in promoting its establishment and maintenance within
the host's system[11]. Alternative virulence traits can be exploited by S. aureus when one trait is
selectively inhibited by a certain anti-virulence agent. From one of the recent studies conducted
by our lab, the monomer-dimer equilibrium of sortase A plays a critical role in regulating the
enzymatic activity, which in turn controls the microbial pathogenesis[12].The data from our lab
has suggested that the S. aureus mutant, which expresses sortase A in a monomeric form,
displays more surface adhesive proteins than that of the cells expressing the wild-type
enzymes[12]. To our knowledge, an unknown signal molecule that interacts with sortase A is
involved in the control of the dimer-monomer equilibrium to regulate the related biological
functions on the cell membrane. Sortase A exists as a dimer form when it is inactive and the N
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terminal anchors sortase A onto the surface of the bacteria, see Figure1(a). After Sortase A binds
to mammalian cells and ready to infect, the dimer dissociates and each polypeptide undergoes a
conformational change, seeFigure1(b) and becomes monomeric form, see Figure1(c).

Figure 1. Sortase A form transformation from dimer to monomer.

1.2.2:Sortase A mechanism and hypothesis: signaling pathway of messenger molecule
It becomes natural to hypothesize that the dimerization of sortase A on the surface of S. aureus
hence the bacterial infection responds (senses) to the environment such as the availability of
mammalian cells via molecular interaction. The sensing molecule(s) are most likely from the
mammalian cells and interact with the sortase A dimer before the anchorage of virulence factors
and infection occur. The interaction may stabilize the sortase A homo-dimer which deactivates
the enzymatic activity and the subsequent display of virulence factors, bacterial infection will be
inhibited by such "positive" sensing molecule(s) from the perspective of host mammalian cells.
On the other hand, the interaction may stimulate the dissociation of sortase A dimer which
activates the enzymatic activity and the subsequent display of virulence factors, bacterial
infection will be promoted by such "negative" sensing molecule(s). In other words, the unknown
ligand termed the messenger molecule and this unknown molecule, X regulate the transformation
of Sortase A of the gram-positive bacteria. Dissociation of dimerized sortase A into the
monomeric form can therefore activate the downstream signal by actively transporting various
adhesive proteins and other virulence factors onto the bacteria surface, initiating the bacterial
invasion and internalization. And Collagen V as a defense system can prevent Sortase A
transformation. The interaction between dimeric sortase A and the X-messenger molecule is an
effective mechanism to target for the development of promising antibacterial or anti-infective
therapeutics in combating the antibiotic-resistant strain.
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Chapter 2. Methods
2.1:Bio-AI detection model to identify X molecule
A complete proteome list of the CHO cells are crosslinked with sortase A, the covalently bound
proteins of CHOcells to sortase A suggests potential candidates of the messenger moleculeX [13]
[14] [15]. Several machine learning methods have been developed and deployed to predict the
most likely protein candidates for the wet lab experiment validation.
2.1.1: Introduction of the database and Functional Proteomics
The total potential protein candidates composed of the raw database was obtained from Liquid
chromatography tandem mass spectrometry data by MtoZ Biolabs. SrtA is obtained from E. coli
cells using affinity chromatography and Molecule X is obtained by collecting the entire
mammalian proteome of Chinese Hamster Ovary (CHO) cells. The16SrtA and mammalian
proteome are mixed together with a cross linker to covalently bind Molecule X to SrtA. The
cross-linked products are purified and analyzed using liquid chromatography with tandem mass
spectrometry (LC-MS-MS) and the proteins are identified using a proteomic database. The
resulting data is analyzed for Molecule X candidates by grouping the proteins into clusters based
on function and subcellular location. The identified clusters are calcium ion dependent,
membrane associated, G Protein-coupled receptors (GPCR) associated, and adenosine
triphosphate (ATP) or guanosine triphosphate (GTP) binding proteins [16] [17]. Sortase
A∆59-His6 (SrtA∆59-His6) was purified natively from E. coli according to the established
protocol. The total cell lysate from CHO cells was prepared according to the established
protocol. Purified SrtA∆59-His6 was incubated with the prepared CHO cell lysate at the final
concentration at 0.6 mM. Cross-linking reactions were performed using benzophenone
maleimide (BPM). After the crosslinking, the proteins were purified using Ni-NTA beads to
afford the sortase A-bound protein mixture. The protein mixture was digested with trypsin. The
resulting peptide fragments were analyzed using LC-MS-MS and aligned to a proteomics
database to identify the proteins with their unique trypsinized peptide pattern (Fingerprints),
using software Maxquant. The generated database from mammalian proteome interactions with
Sortase A dimers is attached in the supplemental data in this publication.For more information,
see S1 Appendix.
2.1.2: The significance of Bio-AI performance
There have been few studies and algorithms to perform searches for potential proteins based on
the cross-linking spectrometry databases [18]. Due to this functional database, it is possible for
us to manually add location as a primary consideration as the selection criteria. The aid of the
understanding of biological mechanisms on machine learning algorithms helps weights and bias
to be made optimal to produce the most possible prediction. And thus, the core idea of
Biology-Artificial Intelligence (Bio-AI) requires a working knowledge of biology mechanisms.
Our primary objective is to introduce a working algorithm utilizing Tensorflow and
Principal Component Analysis to understand the cluster of the data better and further aid to
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locate the most possible protein. The raw database yields 184 possible options in36total, it is
costly to test every single candidate. Therefore, it is important to test from the most possible
proteins. And simply by researching manually according to the functions and looking through
existing papers of each protein takes our team months.The algorithm gives similar results only in
a few seconds. The algorithm significantly decreases the time teams would spend on searching,
and with the reliable accuracy, it becomes possible to allocate less funding for unnecessary
antibody purchase for the experiments.
2.1.3: Database variables
There are 184 proteins in total and 10 independent variables with an independent variable
(“Score”). In order to better perform the data analysis, we introduced another variable: “location
weight”, which the values were assigned by each protein’s location. Tensorflow algorithm is
performed using Python on Jupyter Notebook and principal component analysis was performed
separately using Matlab. Figure 2 shows the raw data along with the added on variables for the
identification utilizing the molecule location as a variable.

Figure 2. Mass spectrometry results from MtoZ Biolabs. List of proteins present in sample solutions and
identified through proteomics database comparison, with the manual add column, “locationweight

The raw database includes the following variables: “Protein IDs”, “Number of proteins”,
“Peptides”, “Unique Peptides”, “Sequence Coverage percentage”, “Unique Sequence Coverage
percentage”, “Mol.weight [kDa]”, “Sequence Length”, “Sequence Lengths”, “Q-Value”,
“Intensity” and “Score”. However, the database needs further polish and understanding since it
remains unknown how the score was calculated by MtoZ Biolabs due to logistic reasons. We add
functionality and location of the protein candidates for the purpose of manual protein search. We
primarily focus on the proteins located on the plasma membrane and extracellular region for the
structure and function of gram positive bacterias. Since functionality is hard to quantify, we only
consider location as the add-on variable for the algorithm analysis purpose. From the
understanding of gram positive mechanism, we set proteins where locations are at “plasma
membrane” and “extracellular” as 0.5; “nucleus”, “cytoskeleton”,”golgi apparatus”, “ribosome
site p site”, ‘Endoplasmic reticulum”, and “cytoplasm” as 0.3, and the rest location cannot be
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found via bioinformatics search set as 0.2. We assume that “plasma membrane” and
“extracellular” are the most likely locations that the targeted proteins should be at [19] [20] [21],
therefore, we assign more values on these two locations compared to the others, shown as figure
2. And to better understand the cluster of the data as well as the relation of the data, we decided
to perform both unsupervised and unsupervised learning to help us with the possible best
prediction of the protein.
2.1.4: Principal Component Analysis (PCA) machine learning algorithm
The first attempt of designing an algorithm is the use of PCA [22] [23]. In many applications, to
interpret data with a large number of variables in a meaningful way, it is essential to reduce the
number of variables and interpret linear combinations of the data. Principal Component Analysis
(PCA) is an unsupervised learning technique that uses sophisticated mathematical principles to
reduce the dimensionality of large datasets [24] [25]. It is used as a method applied on the data
matrix to investigate if we are able to get the similar output for our existing datasets. All the data
is normalized to get the “Z-value” for the most optimal comparison. By utilizing this method, it
comes clearer to us which variables take the most important roles in the dataset. Here, we
consider “Score” as an independent variable so that we can perform an unsupervised learning for
the cluster of the dataset. We first plot a pareto plot to prove that PCA analysis on our database
makes sense. See figure 3, there are 6 different principal components available for us to analyze
upon. For the purpose of this protein selection, we decided to use the top 2 and we want to see if
there are any variables that are similar mathematically. From the biplot, figure 4, we can see that
“Score”, “Peptide”, “unique peptide” and different “Sequence Coverage percentage” have a
similar effect on each component.
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Figure 3. Pareto plot on protein datasets for various principal components

Since how the score was calculated remains unknown, it is natural to first drop this variable and
keep the rest. Among the rest, we decided to keep the88“Sequence Coverage percentage”
because of its significance. For different peptides and unique peptides, these values can be
represented by “Sequence Coverage percentage”, however, we are unable to achieve the other
way around in our data set. From the component 2, we see that the “sequence lengths” and
“sequence length” essentially mean the same because most of the data is one protein per cell on
the data sheet but93some have many proteins in one cell (for this, we expand the cells into
individual cell later on for better visualization and comparison). Therefore, we need to keep
sequence length and intensity for component 2. We assume that component 1 and component 2
are sufficient enough to represent the whole consolidated database, we devise this algorithm and
reduce the variables from 10 to 3. Now there are only three variables left which are “Sequence
Coverage percentage”, “Sequence Length” and “Intensity”. We first filtered out all the proteins
where Q-values come out to be “1” because those proteins are considered as outliers. We then
filter out all the cells where there are multiple proteins at once because we do not want the results
to have any bias towards the multiple cells because the intensity is the sum of all the proteins.
Therefore, we only look at the individual protein that shows up individually per cell in the data
sheet. We also filtered out the proteins where the intensity is 0 because from our algorithm we
learned that intensity matters in this database and we would like to keep the proteins where the
intensity is positive. The initial consolidated database with a selection of 114 proteins comes
down to 38 selections. And at this point, it would already be much more efficient to manually
look up each protein. We can further optimize our solution by using the aid of the protein
location at the plasma membrane and extracellular. We came up with 2 outcomes locking only
three variables and filtering them from the highest intensity to lowest as well as ranking the data
“Sequence Coverage percentage” and “Sequence Length” descendly. The filters are done three
times parallel with the location of the plasma membrane or unknown present. With a different
ranking system using “Intensity” or “Sequence Length” or ““Sequence Coverage percentage” we
get different orders of protein. In the regime of using this algorithm, we deduce the possible 38
proteins from the selectivity. With the aid of using protein location parameters we are able to
narrow down protein selections.
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Figure 4. Biplot generated for the cluster of the data matrix

To improve the selection algorithm, we decided to perform a single value decomposition on
the consolidated data set. By doing so, we are able to find the most representative
“eigen-protein”, the protein in the consolidated database that can represent the most charastics of
the datasets. [U,S,V] = svd(A)where A is the database [26]. We perform the single value
decomposition and we multiply the first vector of U and first vector of V with the biggest sigma
to get the most represented protein of the database. And by analyzing the “eigen-protein”, figure
5, we are able to determine which variables matter the most in our consolidated database. In this
SVD transformed dataset, we can see that only principal component 1 dominates the whole
dataset and therefore we only look at component 1 in the corresponding biplot figure. From
figure 6, we see “Intensity” “number of proteins” and “peptides” have similar effects; so we are
able to drop two variables and keep one variable. And component 2 is not significant, so it is safe
to neglect. We exclude the multiple number of proteins to avoid the interference of higher
numbers of intensity so that leaves us “Intensity” and “Peptides”. For the purpose of this
research, we keep intensity since it is the hit intensity with Sortase A. In the end, “Intensity” and
“unique sequence coverage percentage” are the crucial variables. The selection process can be
repeated as mentioned above, ranking the appropriate proteins only this time we can run two
16

parallel rankings to see the outputs. The same result shows for the final selection if we add
location as another parameter for selection.

Figure 5. “Eigen-protein” shows one and only PC.
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Figure 6. Biplot for “eigen-protein”

2.1.5: Deep Learning Algorithm
In the following methods, we assume “Score” is a dependent variable where it is an evaluation of
the values given by MtoZ Biolabs. We perform deep learning by using the Sigmoid function to
get the weights of each variable [22]. Each initial weight is assigned manually based on the
importance of the variables as the following: [-2,-1,-1,2,2,-1,-1,-1,-2,2,1], which corresponding
to the following variables: [“number of proteins”, “peptides”, “unique peptides”, “sequence
coverage percentage”, “unique sequence coverage percentage”, “mol.weight”, “sequence
length”, “sequence lengths”, “score”, “intensity”]. Then we use the sigmoid function to take into
account bias to adjust the weights and finally conclude with the most optimal weights after
repeating the weight adjustment process for about 10,000 times. The optimal weights generated
by using the training process. Then we use the weights to multiply back to the variables and
conclude with the final evaluation. The last step is to rank the results, following this
mathematical model: Y=f*(W1xT+W2xT+...+W10xT+WlocationxT+b), where f is the Sigmoid
activation function, W is the set of the parameters or weights in the layer and x is the input
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vector, which is the output of the previous dense layer, and b is the bias vector. Wlocation is
added manually set and it corresponds as the manually added location variable in the dataset.
With the corresponding evaluation Y, we are able to rank the results of the protein from the most
likely to the least likely.
2.1.6: Deep Learning Algorithm via Tensorflow
The purpose of the usage is to build a model with the existing database, then we split the dataset
with some training data and some test data for the validation, and the algorithm can be used for
the prediction of the current database and future protein candidate. In this way, we improved the
initial random guess and adjusting cumbersome and came to a clean weight for the nodes. We
build the model by first defining some metrics and the goal of it is to have a good accuracy. The
model is defined by using keras and one dense layer with 11 nodes and a Sigmoid layer as the
activation layer for the two possible outcomes: “Prediction Yes” and “Prediction No” (figure 7).
With the model defined using the sequential model [27] [28] [29], it is possible to add as many
layers as possible. But for our database purpose, one dense layer along with the Sigmoid layer

Figure 7. Neural network for the prediction of Protein Search

are sufficient enough. The layer weights are retrieved and along with the self-defined weights on
the location parameter, we are able to give an evaluation for each of the proteins provided by the
datasets; follow by the same mathematical model used above. In the built model. We then rank
the candidates and find the top five ranked ones to compare with the result that we achieved
manually. The model gives 118 possible “Prediction Yes” out 184 possible candidates and the
accuracy is high (0.946). The prediction gives the probability of how likely each candidate is a
yes using the built model. The prediction model can be further applied to other new proteins
where it is applicable. The weights can be optimized by running more epochs and taking bias
into account to minimize the loss, see figure 7 for the Train zero bias and train careful bias.
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Figure 7. Epoch against loss on Train Zero Bias and Train Careful Bias

2.1.7: Results of the Bio-AI implementation
A total of potential targets of proteins were incorporated in both deep learning and machine
learning algorithms. Due to the nature of the database, we assumed “Score” as the independent
variable for the purpose of Deep learning development and we assumed “Score” as an
independent variable for the machine learning algorithm.
Five protein candidates were manually selected using Bioinformatics. Potential targets were
identified by species, duplicates, abundance, and cellular location by manually evaluating the
data attributes.
Table 1 shows the top five candidates we got from manual search by bioinformatics and the first
four are the same results we concluded from the silicon algorithm. The table also listed the
BIO-AI result and the ranking.
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Protein

Intensity

Antibody

Funcation

Location

Bio-AI hit &
Rank

G3H5I4

44038000

Neuropeptide
Y2
Polyclonal
antibody
(NPY)

Neuropeptid
e Y receptor

Plasma
membrane

Yes: 2

G3HTG1

34546000

Anti-DOC2B
Monoclonal
antibody

Calcium
dependent
phospholipid
binding

Plasma
membrane

Yes: 4

G3IL75

33571000

Recombinant
Anti-Collage
n V antibody

Extracellular
matrix
structural
constituent

Extracellular
region

Yes: 3

G3HIP9

22567000

ADAMTS12
Polyclonal
antibody

Metalloendo
peptidase
activity

Extracellular
region

Yes: 3

G3IHL7

22374000

Cathepsin L
Monoclonal
antibody

Cysteine-typ
e peptidase
activity

Extracellular
Region or
secreted

No: no
significant

Table 1. Results from the manual search corresponding to the BIO-AI algorithm.

We also listed the antibody that we use to test to affirm the accuracy. Of the top five candidates
that our lab picked by human bioinformatic search, four out of five show significant results
which indicate that the targeted protein of the top four in table 1(marked in red) are the correct
predictions. Among the four results, two show the most relevant results and indicate the
significance of the mechanism of Sortase A gram-positive bacteria infection pathways. Antibody
(NPY Y2 receptor) acts as an inhibitor. Peptide reacts with Y2- mammalian surface receptor
which inhibits activation of srtA which indicates more NPY peptide, less invasion by
gram-positive bacteria. Another protein identified is Collagen V. For the purpose of this master
thesis, the discovery of Collagen V as the targeted protein will be intensively discussed. More
test results from the lab can be found in other related papers and documentations published from
Zhang Lab Santa Clara University Bioengineering department.
The result of the Bio-AI algorithm using the clusters of the data and the features of the
dataset significantly decrease the bioinformatics search time and brings the most likely result for
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researchers with more efficient search compared to manual bioinformatics using only papers and
results published from other related labs. The performance of this Bio-AI search utilized both
machine learning and deep learning. Deep learning where we consider “Score” as an evaluation
and we use the regression and Sigmoid function to build predictive proteins. And it is a
subcategory of machine learning. Machine learning method is more of a statistical method where
we use the row reduction to filter through the dataset. The boundary between machine learning
and statistical methods is fuzzy (Xu et. al) [30]. However, machine learning and statistical
methods have different focus, inference and predictions [31]. In our case, the statistical method
gives a clear algorithm of the filtering and it works the best for our specific dataset. The machine
learning algorithm derived using deep learning method and Tensorflow platform gives good
prediction and tool for future protein search and classification.
2.2:Wet lab experiment validation
In order to perform the validation of the proposal of the mechanism and BIO-AI accuracy, we
perform the wet lab experiments to validate the hypothesis that were previously mentioned.
Although four of the five candidates are all performed in Zhang lab, only one of the most
significant results, collagen V will be discussed in this thesis.
2.2.1:Wet lab experiment five candidate introduction
Five candidates were manually selected from the Zhang lab researchers. NPY-Y2 receptor was
selected because it is located in the plasma membrane and is part of the stress response. Double
C2-like domain-containing protein beta was identified because it is located in the plasma
membrane and domains of C2 interact with membranes. The Collagen alpha-1(V) chain was
identified as it is part of the extracellular region and can be the target of surface-anchored
virulence factors. Also selected were A disintegrin and metalloproteinase with thrombospondin
motifs 12 a metalloendopeptidase in the extracellular region and cathepsin M a Cysteine-type
peptidase also found in the extracellular region. Table 1 shows the functions and locations of the
five potential candidates.
2.3:Wet lab experiment method and handling
2.3.1 Chemicals
All chemicals used in conducting all followed experiments are research grade reagents from
ThermoFisher Scientifics unless otherwise mentioned.
2.3.2: CHO Cell Recovery, change media, passage and cell freeze
The CHO-K1 (CCL-61TM) cell line was purchased from ATCC and used as the host cell for
subsequent bacterial invasion experiments. Upon receipt, the frozen cells in liquid nitrogen
vapor, until ready to use. Chinese Hamster Ovary (CHO) cells are considered as ideal hosts for
the evaluation of the degree of infection for they are a type of ovary-derived epithelial cell line
that is susceptible to S. aureus bacterial colonization and infection. In order to prepare for the
CHO cell culture process, all media, including Dulbecco’s Modified Eagle Medium with high
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glucose (DMEM, 4500mg/L, Sigma-Aldrich) and Fetal Bovine Serum (FBS), need to be warmed
up to 37 °C in a water bath. The CHO-K1 cells were removed from the liquid nitrogen vapor and
immediately placed in the 37 °C water bath for fast thawing. To minimize the exposure of the
damage from dimethyl sulfoxide (DMSO) that was used as the cryopreservation reagents, frozen
cells are thawed quickly in the water bath right after taken out from the liquid nitrogen. DMSO
can passively diffuse through biological membranes and helps prevent the formation of both
intracellularly and extracellularly disruptive crystals in cells during the freezing process by
collectively lowering the freezing point of the solvent mixture. But at the same time, DMSO is
also cytotoxic toward the cells, making it necessary to thaw cells at a rapid rate to facilitate the
quick dilution and removal of DMSO from the immediate aqueous environment to better cell
survival and viability. Thawed cell sample was added to a 15 ml falcon tube, followed by a slow
rate of addition of 3ml of fresh DMEM to avoid osmotic shock to the cells. Dethawed cells
mixture was then centrifuged at 3000 rpm for 1 minute. The cell pellet was collected and
resuspended in 2 ml of DMEM with 15% FBS. The mixture was then added to a 100 mm tissue
culture dish (CELLSTAR®) that contained 5 ml of DMEM/15%FBS. The tissue culture dish was
tilted ten times to allow the cells to evenly distribute above the plate surface.
The cells are checked every 24 hours to ensure that the media is fresh and no bacteria or other
contaminations. The media is changed around every 24 to 48 hours depending on the freshness
of the media.
The cell growth is monitored by the microscope. If the cells look healthy and reach to about
80% confluency, the passage can be performed. The monitor of the CHO cells need to be done
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Figure 8: Healthy looking CHO cells V.S. bacteria infected cells.
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daily to avoid the bacterial infection. If and when bacteria infected CHO cell culture, the culture
of the plate should be discarded immediately. See figure 8 for the difference between healthy and
bacterial infected CHO cells. Before detaching cells, wash the cells with PBS for at least three
times and then add 2 ml of Trypsin/EDTA that is just enough to cover the cells surface. the
surface of the dish. Once added, the plate needs to be transferred to the incubator of 37°C for 5
minutes and quickly remove the plate from the incubator and dilute the plate with 5 ml of fresh
media. After centrifuge the cells for 3000 rpm for 1 minute, the supernatant should be removed
without disturbing the cell pellets. Then we recollect the cells by suspending them in the media
and plate them on to two plates if performing 1 to 2 splitting.
When the cell quantity reaches to the point of what we need, cell freezing can be performed to
have future stock and experiment. The freezing media is made of 20% FBS and 10% DMSO.
After the cells are stored in the freezing media, they are transferred 1 mL of freezing
resuspension into an eppendorf tube and Stored in -80°C mammalian cell culture fridge in a
styrofoam box overnight then stored in liquid nitrogen for future usage.
2.3.3: S. aureus TSB+Agar Plating
The chemically and radiologically mutated Staphylococcus aureus (S. aureus) strain, RN4220,
was obtained from the Zhang’s Lab and was used for infecting CHO host cells. 4 g of dehydrated
Tryptic Soy Broth (TSB) agar (Sigma-Aldrich) was dissolved in 100 ml of purified deionized
(DI) water and autoclaved at 121°C for 15 minutes. The sterilized TSB agar media was allowed
to cool to 60°C in a water bath and dispensed 10 ml per sterile Petri dish (VWR). The cell stock
obtained from the -80 °C freezer was placed on ice for thawing. A loopful of bacterial culture
was streaked onto the TSB agar plate in a zigzag pattern. It is necessary to work in the sterlized
environment due to the fact that no antibiotics were added in RN4220 to prevent contamination.
The colonies were grown upside down in a 37 °C incubator overnight and stored in a 4 °C fridge
for short-term usage.
Two sets of RN4220 were prepared. One set will be labeled using CFSE byadding 8μl of CFSE
stock solution to the 4ml culture to achieve a 10μM concen-tration. CFSE-labeled bacteria are
washed with 2 ml of Dulbecco’s PhosphateBuffered Saline (PBS; Sigma, St. Louis, MO) 3
times. Protect fluorescent-labeled bacteria from direct light exposure by wrapping it with
aluminum foil.Check OD after resuspending cell in PBS before invasion assay with PBS as
blank. Mix bacterial cells with CHO cells in one of the 6 wells at a MOI of 40.The total RN4220
needed is as follows, where V is the volume of the culture.Total bacterial needed denoted as N.
See equation 3 for more detail.

A Knock-out aureus (KOA) strain bacteria also tested to validate the hypothesis. The preparation
process of the is the same as the (S. aureus) strain, RN4220.
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2.3.4 CFSE-Labeling of S. aureus
Tryptic soy broth media was prepared by adding 7.5 g of TSB power (The Lab Depot) into 250
ml of DI water. The mixture was autoclaved at 121 °C for 15 minutes and stored in a 4 °C fridge
for future use. Two single RN4220 colonies were picked from TSB agar plate and separately
inoculated in two culture tubes (FalconTM) with 5 ml of TSB media for 10 to 12 hours.
According to the log variable of the bacterial growth curve, the ideal inoculation time is during
the exponential growth time. Thus, we prepare the inoculation process overnight [32].

Figure 9. The typical bacterial growth curve. When bacteria are grown in a closed system (also called a
batch culture), like a test tube, the population of cells almost always exhibits these growth dynamics: cells
initially adjust to the new medium (lag phase) until they can start dividing regularly by the process of
binary fission (exponential phase). When their growth becomes limited, the cells stop dividing (stationary
phase), until eventually they show loss of viability (death phase). Note the parameters of the x and y axes.
Growth is expressed as change in the number of viable cells vs time. Generation times are calculated
during the exponential phase of growth. Time measurements are in hours for bacteria with short generation
times.

The optical density (OD) of the 5 mL small scale cultures were measured at a wavelength of 600
nm using a spectrophotometer after washing the media culture for at least three times with TSB
as a control to get the accurate OD measurement. A plain PBS was used as a blank for the
measurement. Ideally, the OD600 of the bacterial culture should stay within the range of 0.4-1.0
to collect the bacteria at its exponential growth phase. RN4220 cell cultures were then
centrifuged at 5000rpm for 5 min to obtain cell pellets. The collected cell pellets were thoroughly
resuspended with 2 mL of phosphate-buffered saline (PBS). 5 mM CFSE-staining stock solution
was prepared by adding 18μL of anhydrous DMSO into one vial of CellTraceTM CFSE dye. 4
μL of 5mM CFSE-staining stock solution was added to each of the 2 ml of bacterial culture in
PBS to achieve a final concentration of 10 μM. The culture tubes were wrapped with aluminum
foil to prevent photobleaching and incubated in a 37 °C shaker at 225 rpm for one hour. Labeled
S. aureus cultures were washed with 2 ml of PBS three times to remove excessive, extracellular
CFSE dye molecules. The pellet cells were collected at 5000 rpm for 5 minutes and resuspended
in 1 ml of PBS. CFSE-labeled S. aureus was protected from direct light exposure and stored in a
4 °C fridge until conducting an invasion essay.
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2.3.5 Hemocytometer Cell Counting
Prior to the invasion assay, a defined amount of CHO cells was estimated and passaged into a
100 mm tissue culture plate. The CHO cell numbers were quantified using a hemocytometer. The
volume amount of the used DMEM/10%FBS media to collect trypsinized cells was recorded. 20
μL of the cell suspension was mixed with the same amount of 0.4% trypan blue solution
(Sigma-Aldrich) to exclude dead cells as the dye can selectively color dead cells with
compromised membranes blue. To achieve a statistically significant count, a minimum number
of cells needed should be approximately 100 cells in selected squares of the counting grid. 15 μL
of the cell suspension was pipetted into one hemocytometer chamber that was covered with a
coverslip on top. By counting the total number of cells under a microscope with 10X
magnification on four big squares located at the corners, cell concentration can be determined
using the following formulate (do not count the cells touched the bottom and right sides of the
square):
[Total CHO Cell]=(Total cells count * initial volume * dilution factor * 10^4)/(# of square
counted)
CHO cells were prepared the night before for at least 17 hours into six-well plates without
significant events of cell divisions to ensure the multiplicity of infection (MOI) at the invasion
assay. Cell counts were used by a hemocytometer chamber. The four corners were counted with
the dilution factor of 2. The total cell formula was used as the following, where X1 is total cell
count, X2 is initial volume of the culture,dilution factor is 2 and n is the 4 square counted cells.
Equally distributed the CHO cells in the 21 wells and the CHO cells in each well is denoted as
W;volume added in each well is denoted as m.

2.3.6 Antibody target: Collagen V, as the defense system
The target of the antibody was purchased based on the performance of the BIO-AI result. To be
specific, the collagen V was tested intensively to validate the performance of BIO-AI.
We performed a machine learning sigmoid regression to predict the signal molecule
candidates in our proteomic datasets via Tensorflow and checked against our top results with the
validation of laboratory experiments. Unsupervised learning was utilized to find the clusters of
the datasets with the aid of sigmoid activation function to predict the likelihood of the potential
targets. One of the most promising predictions is type V collagen. Mammalian proteins
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containing a collagen-like region acts a crucial role in host defense.Bacterial collagen-binding
protein interacts with soluble defense collagens can give pathways for pathogens to evade the
host immune response [33,34]. Gram-positive pathogens utilize their interactions with the ECM
for tissue colonization and to establish infections in the host. Type V collagen is known for its
function of regulating fibrillogenesis whichact as cellular receptors and facilitate cell adhesion
and as soluble collagen in ECM upon cleavage [35]. In a recent study, CollagenV was identified
as an instrumental element of limiting cardiac scars and wound healing [36]. In this paper, we
identify that collagen V, acts as the potential signaling molecule that involves in inhibiting the S.
aureus bacterial infection and disrupting its intracellularly into the host cell by conducting a
disruptive assay used RN4220 in internalizing into non-professional phagocytic cells, Chinese
hamster Ovary (CHO)-K1 cells (CCL-61TM)line, as the experimental host with the addition of
anti collagen V antibody. As Demonstrated by previous studies (29, 30), carboxyfluorescein
succinimidyl ester (CFSE) dye can adequately label S. aureus without affecting its viability[37].
Seven sets of samples are prepared: A. Negative Control: no antibody and no CFSE labeled
RN4220; B. Positive Control: no antibody with CFSE labeledRN4220.C.0.2μg/ml concentration
of antibody and CFSE labeled RN4220.D.0.5μg/ml concentration of antibody and CFSE labeled
RN4220. E.1μg/mlconcentration of antibody and CFSE labeled RN4220. F.2μg/ml concentration
of antibody and CFSE labeled RN4220. G.8μg/ml concentration of antibody CFSE labeled
RN4220. Add the sets of antibodies before adding RN4220for at least 30 minutes. Inoculate for
60 minutes in 37◦C For invasion. Terminate the bacterial invasion by adding gentamicin to the
media to achieve a final concentration of 300μg/ml. Wash the infected cells using PBS 3 times
before fix the cells with with paraformaldehyde solution 4% in PBS to achieve a cell
concentration of 1*10^6CHO cells/ml for data analysis. The performance of the positive control
was done to ensure the accuracy of the technique of the researcher.

2.3.7 Invasion Assay
Prior to the invasion assay, the CHO DMEM/10% FBS media was replaced with pure DMEM.
The chosen antibody needed to be added prior to the performance of the bacteria invasion for one
hour.. The CFSE-labeled RN4220 were added to the CHO cell culture at a Multiplicity of
Infection (MOI) of 20. RN4220/CHO mixture was allowed to incubate at 37 ℃ for 60 minutes.
18 μl of 50mg/ml gentamicin stock solution was added to achieve a final concentration of
300 μg/mL of the media. The gentamicin solution was evenly spread on the tissue culture plate
by gentle tilting. The culture was allowed to be inoculated at 37 ℃ for 30 minutes.
RN4220-infected CHO cells were washed with 3ml PBS three times to remove extracellular
bacteria that did not invade the CHO cells. The OD was measured with the PBS as the baseline
control for accuracy.
2.3.8 Fluorescence Microscopy
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RN4220-infected CHO cells were observed under BZ--X710 fluorescent microscope to ensure
the successful internalization of the bacteria into the CHO cells’ cytoplasm. Both brightfield and
fluorescence images were obtained and overlapped to observe the degree of invasion. To prevent
excessive photobleaching caused by the fluorescence microscope, a short amount of time should
be used for the observation.
2.2.9 Flow Cytometry
2 ml of 0.25% Trypsin-EDTA solution (Sigma-Aldrich) is added to the tissue culture dish to
detach the infected CHO cells. The mixture was placed in 37 °C for 4 minutes and observed
under the light microscope to ensure a high degree of CHO cell detachment. If necessary, the
plate should be gently tapped on the bottom to facilitate the detachment. 5 ml of DMEM/10%
FBS was added to each well to neutralize or inactive the effects of Trypsin-EDTA solution. The
trypsinized CHO cell mixture was centrifuged at 100 g for 5 minutes, and the CHO cell pellet
was collected and resuspended with an appropriate amount of paraformaldehyde (PFA) solution
4% in PBS to achieve a final cell concentration of 1 x 106 cells/ml and fixed for 15 minutes to
prevent cellular decomposition during the analysis period. The PFA-fixed sample was filtered
using a 40 μm cell strainer to remove cell aggregations from the cell suspension to achieve a
uniform single-cell suspension. The sample should be kept at 4℃ and dark until the analysis. BD
AccuriTM C6 Plus flow cytometry was used to collect 100,000 events per sample. By gating
1 × 10^4 CHO cells per sample based on forward and side scatter, CFSE-associated fluorescence
was measured in fluorescence channel 1 (FL1-H). The uptake index (u.i.) is used to estimate the
amount of internalized bacteria by multiplying the percentage of CFSE-positive cells with the
mean fluorescence intensity of these cells. The u.i. Is converted to be a percentage unit to
uniform the analysis performed from different experiemnts.
CHAPTER 3: Results and Data Analysis
3.1 Fluorescence Microscopy
In order to demonstrate CFSE dye had successfully stained the S. aureus, the first step is to have
two groups of CHO cells with the same cell density infected with either the non-CFSE-stained
(Control) or CFSE-stained bacteria (Sample). As shown in Figure 10(B), after 45 minutes of
termination of bacterial infection using gentamicin, no S. aureus had shown green fluorescence
under the fluorescence microscopy for the control group. As indicated by the overlapped image
in Figure 10(C), the majority of the non-CFSE-labeled bacteria appear to either successfully
adhere to or internalize into the CHO cells, suggesting the invading ability of the S. aureus. As
shown in Figure 11(B), S. aureus that had been incubated in CFSE staining solution with a final
concentration of 10 μM was shown a strong fluorescence intensity, indicating the bacteria had
been successfully labeled. Neither bacterial viability nor invasion ability are affected by the
CFSE staining. The bacterial internalization had been confirmed by the overlap images in Figure
11(C) and 11(D), in which S. aureus was entrapped within the cytoplasm of the CHO cells with
no vibrational behavior observed under the microscope.
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Figure 10. Fluorescence Images of Non-CFSE-Labeled-Bacteria-Infected CHO Cells under 40X
Magnification Part A. (A) Brightfield; (B) Fluorescence; (C) Overlap.
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Figure 11. Fluorescence Images of CFSE-Labeled-Bacteria-Infected CHO Cells under 40X Magnification
Part B. (A) Brightfield; (B) Fluorescence; (C) Overlap; (D) Zoom-in view of white rectangular region in (C).

3.2 Flow Cytometry
The degree of internalizations of S. aureus into the CHO cells with the presence and absence of
anti collagen V antibody, in the culture media were determined using the flow cytometry as
shown in figure 1. CHO cells that are in single-cell suspension were selected by plotting a
forward scatter area (FSC-A) versus a forward scatter height (FSC-H) (Figure.12, d-h). As
compared to the CHO cells treated with non-CFSE-stained S. aureus (Figure. 12a) in which only
one peak had been observed for the negative control, indicating a homogeneous CHO cell
population with no detected fluorescence activity, two peaks had been observed due to a mixed
CHO cell population that is either fluorescent (positive) or non-fluorescent (negative)(Figure. 12,
b and c). By setting a control marker (Figure. 12a) on the left to include 95.09% of the
fluorescent intensity data from the negative-control histogram, the CFSE-positive marker, which
accounts for 4.01% of the population, represents the CHOcells with fluorescence intensity that
are situated outside of the boundary of three standard deviations of the negative control
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population. The exact same CFSE-positive markers had been applied to the rest of the
CFSE-stained bacteria-infected CHO cell samples anti collagen V to quantify the relative
percentage of the weakly positive samples (Figure. 12c for concentration 0.5μg/mlas a
demonstration). Each of the CHO cells were treated in triplicate sets to ensure accuracy with
different concentrations. A General trend of increased bacterial internalization had been observed
when there was an increased amount of free anti collagen antibodies present in the culture media.
An estimate of the amount of internalized bacteria was calculated by multiplying the percentage
of CFSE-positive cells with the mean fluorescence intensity (FITC-A) of these cells to obtain the
uptake index(u.i.) [38]. To indicate the true degree of internalization of S. aureus into the CHO
cells, the uptake index (u.i.) was introduced and calculated:
u.i.=% of fluorescent cells *Mean FITC-A
We represent the u.i. in percentage with a default 100% for the positive control u.i. (RN4220
with dye no antibody), taking the average of the triplicate and comparing each of the treatment
u.i. to the positive control result in percentage. The results show that there is a significant
bacterial uptake increase starting from concentration of 0.5μg/ml with a p value 0.002 (at 95%
confidence interval). The average.i. of concentration 8 μg/ml went up by 2.2 times with a
229.35% u.i. Percentage.

Figure 12. CFSE negative control and CFSE positive control with 0.5μg/ml anti-collagen addition.

3.2 .1 Flow Cytometry technique
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In order to ensure accuracy of the technique of the lab researcher, each researcher needs to
perform several experiments of positive control. Each batch of the performance constituted a
positive control triplicate set. The first positive control, denote (PO_1) as the baseline and mark
as 100% and compare the other two positive control samples (PO_2 , PO_3) with it. See figure
13, the first positive control u.i. denote as 100%, and the second measured as 102.2% and the
third measured as 101.8%. The difference among the triplicate samples is within 3%, which is
acceptable for the purpose of our experiment and a validation of the accurate technique.

Figure 13. Demonstration of triplicate positive control to ensure quality.

3.3 Data analysis
3.3.1 u.i. Curve as demonstration of collagen as a defender for Gram-positive bacteria infection
The fluorescence percentage and mean FITC-A raw data as shown in table 2. The u.i. can be
calculated and shown in table 3.
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Table 2. Anti collagen triplicate fluorescent percentage and mean FITC-A data

Table 3. Anti collagen triplicate mean u.i and respective percentage

A sigmoidal standard curve had been applied to fit the data with a R^2value of 0.99778 see
Figure 14. The result of the increase of bacterial uptake increase is a strong indicator that type V
collagen is the inhibitor of gram positive infection.
Our data suggests bacterial uptake had been enhanced when anti Collagen V antibody was
added. Potential Therapeutics that specifically enhance the collagen V can be developed to either
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prevent or treat Gram-positive infection without imposing a high degree of evolutionary pressure
that deepens the antibiotic-resistance crisis in the modern healthcare system.

Figure 14. Anti Collagen triplicate u.i. Increase with the increment of more antibodies.

3.3.2 Further analysis
In this section, we analyze if the samples added with antibody show a significance compared to
the control sample despite that we see the u.i. increase at 8 µg/ml is almost 2.3 times compared
to the positive control result.
Since the sample size is very small, a student T test will be used.
A hypothesis testing is performed and stated as the following:
Assumption/Null hypothesis: there is no significant difference between the positive control and
each titration sample
Null hypothesis: There is no difference between the positive control and antibody titration
samples at 95% confidence interval. If <0.05, reject the null hypothesis, meaning the result is
statistically significant and there is a difference between the ones with antibody and the sampel
without any antibody. Table 4 shows the student T test data p value and all the results are
significant for different levels of titration compared to the positive control. Therefore, it is safe to
further conclude that collagen can be used as a defender for gram-positive bacteria infection.

Table 4. Anti collagen triplicate P value using t test at significance level of 0.05 and 0.2.
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Table 5 shows the comparison of two titration levels to investigate the effect of each titration. As
the result shows, there is not much difference when compared with the titration among 0.2
µg/ml, 0.5 µg/ml and 1µg/ml. The difference is significant starting from 2 µg/ml. This can be
further investigated and tested at a clinical level.

Table 5: Anti collagen triplicate P value using t test at significance level of 0.05.

3.4 Confirmation on monomer-homodimer equilibrium
3.4.1 Monomer-homodimer equilibrium on RN4220
The hypothesis indicates that the interaction between the Sortase A and Collagen V signaling
pathway plays an instrumental role in defending S. aureus into the host by hindering SrtA from
turning dimer structure to monomer structure and thus preventing the invasion of the mammalian
cells. A demonstration of the proposed equilibrium is shown in figure 15.

Figure 15. Dimer-Monomer Equilibrium in Native State of RN4220.

3.4.2 Monomer-homodimer equilibrium on Knock-out aureus (KOA) strain bacteria
A control experiment was performed on Srt A knockout, a bacteria engineered in the monomer
form, and with the anti-collagen V increases till 0.5µg/ml, mammalian cells start to lyse
significantly (see comparison of lysed cells in different titration in figure 16) with a p value
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0.023 (See figure 17).

Figure 16. Invaded CHO cells lysed and no more cells are detected.

Figure 17. Anti Collagen vs KOA triplicate u.i. in percentage.

This proves that the Collagen V as a defender can prevent SrtA from monomerization, further
preventing the bacteria invasion. However, because of the form of the KOA bacteria engineered
as monomer form, the equilibrium no longer stands. Thus, the defense system collapses and
dampers the ability of Collagen V as a defender agent (see figure 18 for demonstration).
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Figure 18. Native State of KOA with Anti-Collagen no longer in monomer-dimer equilibrium.

CHAPTER 4: Discussion and Conclusion
4.1 Bio-AI and its use
The preliminary laboratory experiments on the Collagen V antibody have significant results. The
result of the Bio-AI algorithm using the clusters of the data and the features of the data set
significantly decreases the bioinformatics search time and brings the most possible results for
wet lab testing. This is a significant improvement from both economical and time wise speaking.
However, for further validation, it is necessary and important to introduce wet-lab testing.
Despite the data showing the accuracy results is 94.6% and the precision is 100%, it is crucial to
know that the dataset is an extremely small dataset and it is normally common to require 5000
data points to perform Tensorflow using Neural Network. Thus, the results of the prediction
cannot be completely concluded without further inclusion of the data and more tests.
4.2 Cell lyses and fixation
Despite the results showing significant lyses of the KOA invaded cells, it is reasonable to always
assume this happens because of chance as a factor. The samples are all fixed with chemicals on
ice during the waiting period. The internalized S. aureus might further proliferate and replicate,
further triggering cell death mechanisms, such as apoptosis. The internalized bacteria that are
released into the PBS media would be excluded from the selected population as indicated by the
gate, rendering a relatively decreased detection of the fluorescent CHO cell population as a
result. Fixation is a process of preserving biological tissues or samples from degradation caused
by any ongoing biochemical reactions. This process allows the preservation of biological
materials as close to their original structural state as possible. By utilizing cross-linking fixatives
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such as formaldehyde and glutaraldehyde, most cellular macromolecules, such as proteins and
nucleic acids, can be covalently cross-linked and stabilized by the formed methylene bridges via
the primary amines on those macromolecules. In addition, chemical fixation by enabling the
cross-linking formation might enable the mechanical strength or rigidity of the cells, allowing
their morphology to remain intact for the flow cytometry analysis during the waiting period.
CHAPTER 5: Future Work
5.1 Bio-AI further validation
More data points should be added via more cross-linking proteomics performance. And more
concrete results should be given on what are the known predictions of the target molecules to
further study and confirm the accuracy of the Bio-AI algorithm. More data given can ensure the
quality of the training data to be more accurate and avoid the overfitting due to the small dataset
cavity.
Furthermore, the algorithm currently is considered a “Fuzzy algorithm” where we only take into
consideration the molecule’s location. More parameters should be added in order to complete the
algorithm. Further parameters such as gene expression level, MRNA expression level number,
genomic of that cell receptors can be further studied and added to the dataset to ensure the
quality of the prediction model and results.
5.2 Collagen V as a treatment therapy
Our preliminary data and results show the significant bacteria defense by introducing Collagen
V. It is safe to conclude that it would be a good time to move on to in vivo, such as animal
models or clinical trials. A therapeutic significance should be expected and it would be safe to
conclude that one could intake more collagen V to defend against gram positive bacteria
infection once the in vivo and clinical trials also show significant results.
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Appendix
Appendix A: The Overall prediction of Bio-AI hit and human search alignments

Appendix figure 1: The overall prediction outcome using BIO-AI and its UI results

Appendix B: Uptake Index of bacteria cell into mammalian cell with increasing titration of
Anti-NPY concentration
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Appendix figure 2: NPY and Anti-NPY results

Appendix C: Sortase A mechanism equilibrium with Collagen V as a defender and NPY
receptor as Traitor
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Appendix figure 3: NPY and Anti-Collagen act as Traitor and defender in the mechanism

Appendix figure 4: NPY and Anti-Collagen act as Traitor and defender in the mechanism shown in KOA
presented in monomer without nature defense system

Appendix D: Bio-AI code Matlab File
opts = spreadsheetImportOptions("NumVariables", 13);
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% Specify sheet and range
opts.Sheet = "Sheet1";
opts.DataRange = "A2:M115";

% Specify column names and types
opts.VariableNames = ["ProteinIDs", "NumberOfProteins", "Peptides",
"UniquePeptides", "SequenceCoverage", "UniqueSequenceCoverage",
"MolWeightkDa", "SequenceLength", "SequenceLengths", "Qvalue", "Score",
"Intensity", "location"];
opts.VariableTypes = ["string", "double", "double", "double", "double", "double",
"double", "double", "double", "double", "double", "double", "categorical"];

% Specify variable properties
opts = setvaropts(opts, "ProteinIDs", "WhitespaceRule", "preserve");
opts = setvaropts(opts, ["ProteinIDs", "location"], "EmptyFieldRule", "auto");

% Import the data
dt = readtable("/Users/lisajin/Documents/scu/research material/X molecule/Bio-AI
stuff/consolidated.xlsx", opts, "UseExcel", false)

Clear temporary variables
clear opts
%Y = dt(:,12);
X = dt(:,2:12);
X_num=table2array(X);
X=X_num
k = find(isnan(X))'
X(k) = 0
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Z=zscore(X);
%Y_num=table2array(Y);

%yy = sqrtm(inv(cov(Z')))*(Z-repmat(mean(Z,:),1,size(Z,:)));
%[W,s,v] = svd((repmat(sum(yy.*yy,1),size(yy,1),1).*yy)*yy')
[u,s,v]=svd(Z)
proteineigen = u(:,1).*s(1,1).*v(:,1)'%this is the eigen protein
%new=W*Z
%new1=new(1,:)
%new=W*s*v''
%[n, p]=size(X);

[coeffs1, scores1, latent1] = pca(Z);
xlabel('1st PC'); ylabel('2nd PC')
vbls = {'Number of proteins','Peptides','Unique peptides','Sequence coverage
[%]','Unique sequence coverage [%]','Mol. weight [kDa]','Sequence length','Sequence
lengths','Q-value','Score','Intensity'};
biplot(coeffs1(:,1:2),'VarLabels',vbls);
xlim([-0.74 0.74])
ylim([-0.2 0.74])
figure;
pareto(latent1)
xlabel('PC')
ylabel('Variance')

[coeffs2, scores2, latent2] = pca(proteineigen);
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xlabel('1st PC'); ylabel('2nd PC')
vbls = {'Number of proteins','Peptides','Unique peptides','Sequence coverage
[%]','Unique sequence coverage [%]','Mol. weight [kDa]','Sequence length','Sequence
lengths','Q-value','Score','Intensity'};
biplot(coeffs2(:,1:2),'VarLabels',vbls);

xlim([-0.74 0.74])
ylim([-0.74 0.74])
figure;
pareto(latent2)
xlabel('PC')
ylabel('Variance')

%according to SVD PCA analysis, we keep
% "unique sequence coverage[%]"
%"peptides"
%"score"
%Intensity"

%now need to reduce the matrix accordinly
X1 = dt(:,[1 3 6 11 12 14 15]);
X_num1=table2array(X1);
X1=X_num1
%k = find(isnan(X1))'
%X1(k) = 0
Z1=zscore(X1);
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%now assign weights to each variables
% "unique sequence coverage[%]" 0.4
%"peptides" 0.3
%"score" 0.2
%Intensity" 0.1

%assign=Z1[1]*0.4+Z1[2]*0.3+Z1[3]*0.2+Z1[4]*0.1

%run linear regression
Y = dt(:,11);
X = dt(:,[5 8 12]);
X_num=table2array(X);
X=X_num
Y=table2array(Y);
mdl=fitlm(X,Y)

Appendix F: Bio-AI code Tensorflow Neural Network File
import tensorflow as tf
from tensorflow import keras
import os
import tempfile
import matplotlib as mpl
import matplotlib.pyplot as plt
import numpy as np
import pandas as pd
import seaborn as sns
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import sklearn
from sklearn.metrics import confusion_matrix
from sklearn.model_selection import train_test_split
from sklearn.preprocessing import StandardScaler
from scipy import stats
mpl.rcParams['figure.figsize'] = (12, 10)
colors = plt.rcParams['axes.prop_cycle'].by_key()['color']
pip install tensorflow
pip install tensorflow_datasets
import tensorflow_datasets as tfds
pip install tensorflow-cpu
import tensorflow as tf
>>> tf.add(1, 2).numpy()
df = pd.read_csv("/Users/lisajin/Documents/scu/research material/X molecule/Bio-AI
stuff/consolidated2.csv")
headers = np.array(df.columns) # get headers
values = df.values # numpy array of values
matrix = np.concatenate([[headers], values]) # append to the final matrix

data=pd.DataFrame(df).to_numpy()
df1=df
df=df.drop('ID',axis=1)
vector=np.vectorize(np.float)
data=vector(df)
print(df)
print(df1)
# column order in CSV file
column_names = ['Number of proteins', 'Peptides','Unique peptides', 'Sequence coverage [%]',
'Mol. weight [kDa]', 'Sequence length','Sequence
lengths','Q-value','Score','Intensity','locationweight','predictions']
feature_names = column_names[:-1]
label_name = column_names[-1]
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print("Features: {}".format(feature_names))
print("Label: {}".format(label_name))
df[['Number of proteins', 'Peptides','Unique peptides', 'Sequence coverage [%]', 'Mol. weight
[kDa]', 'Sequence length','Sequence lengths','Q-value','Score','Intensity']
].describe()
class_names = ['predictionYES', 'predictionNO']
dt=stats.zscore(df, axis=1)
#without locationweight and ID, THAT CAN BE FOUND IN dt1
y= df.Score
x=df.drop('Score',axis=1)
neg, pos = np.bincount(df['Q-value'])
total = neg + pos
print('Examples:\n Total: {}\n Positive: {} ({:.2f}% of total)\n'.format(
total, pos, 100 * pos / total)) #this seven should be excluded since the Q-value is postive
cleaned_df =df.copy()
# You don't want the `Time` column.
cleaned_df.pop('Score')
# Use a utility from sklearn to split and shuffle your dataset.
train_df, test_df = train_test_split(cleaned_df, test_size=0.2)
train_df, val_df = train_test_split(train_df, test_size=0.2)
# Form np arrays of labels and features.
train_labels = np.array(train_df.pop('Number of proteins'))
bool_train_labels = train_labels != 0
val_labels = np.array(val_df.pop('Number of proteins'))
test_labels = np.array(test_df.pop('Number of proteins'))
train_features = np.array(train_df)
val_features = np.array(val_df)
test_features = np.array(test_df)
scaler = StandardScaler()
train_features = scaler.fit_transform(train_features)
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val_features = scaler.transform(val_features)
test_features = scaler.transform(test_features)
train_features = np.clip(train_features, -5, 5)
val_features = np.clip(val_features, -5, 5)
test_features = np.clip(test_features, -5, 5)

print('Training labels shape:', train_labels.shape)
print('Validation labels shape:', val_labels.shape)
print('Test labels shape:', test_labels.shape)
print('Training features shape:', train_features.shape)
print('Validation features shape:', val_features.shape)
print('Test features shape:', test_features.shape)
x_train,x_test,y_train,y_test=train_test_split(x,y,test_size=0.2)
x_train=tf.keras.utils.normalize(x_train,axis=1)
x_test=tf.keras.utils.normalize(x_test,axis=1)
METRICS = [
keras.metrics.TruePositives(name='tp'),
keras.metrics.FalsePositives(name='fp'),
keras.metrics.TrueNegatives(name='tn'),
keras.metrics.FalseNegatives(name='fn'),
keras.metrics.BinaryAccuracy(name='accuracy'),
keras.metrics.Precision(name='precision'),
keras.metrics.Recall(name='recall'),
keras.metrics.AUC(name='auc'),
keras.metrics.AUC(name='prc', curve='PR'), # precision-recall curve
]
def make_model(metrics=METRICS, output_bias=None):
if output_bias is not None:
output_bias = tf.keras.initializers.Constant(output_bias)
model = keras.Sequential([
keras.layers.Dense(
11, activation='relu',
input_shape=(train_features.shape[-1],)),
keras.layers.Dropout(0.5),
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keras.layers.Dense(1, activation='sigmoid',
bias_initializer=output_bias),
])
model.compile(
optimizer=keras.optimizers.Adam(lr=1e-3),
loss=keras.losses.BinaryCrossentropy(),
metrics=metrics)
return model
model = make_model()
model.summary()
initial_weights = os.path.join(tempfile.mkdtemp(), 'initial_weights')
model.save_weights(initial_weights)
model = make_model()
model.summary()
model.compile(optimizer='adam',
loss='mean_squared_error',
metrics=['mean_squared_error'])
EPOCHS = 100
BATCH_SIZE = 2048
early_stopping = tf.keras.callbacks.EarlyStopping(
monitor='val_prc',
verbose=1,
patience=10,
mode='max',
restore_best_weights=True)
model.predict(train_features[:5])
predictions = model(train_features)
print(predictions)
print("Prediction: {}".format(tf.argmax(predictions, axis=1)))
#print(" Labels: {}".format(labels))
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results = model.evaluate(train_features, train_labels, batch_size=BATCH_SIZE, verbose=0)
print("Loss: {:0.4f}".format(results[0])) #initial loss
initial_weights = os.path.join(tempfile.mkdtemp(), 'initial_weights')
model.save_weights(initial_weights)
model = make_model()
model.load_weights(initial_weights)
model.layers[-1].bias.assign([0.0])
zero_bias_history = model.fit(
train_features,
train_labels,
batch_size=BATCH_SIZE,
epochs=20,
validation_data=(val_features, val_labels),
verbose=0)
model = make_model()
model.load_weights(initial_weights)
careful_bias_history = model.fit(
train_features,
train_labels,
batch_size=BATCH_SIZE,
epochs=20,
validation_data=(val_features, val_labels),
verbose=0)
def plot_loss(history, label, n):
# Use a log scale on y-axis to show the wide range of values.
plt.semilogy(history.epoch, history.history['loss'],
color=colors[n], label='Train ' + label)
plt.semilogy(history.epoch, history.history['val_loss'],
color=colors[n], label='Val ' + label,
linestyle="--")
plt.xlabel('Epoch')
plt.ylabel('Loss')
plot_loss(zero_bias_history, "Zero Bias", 0)
plot_loss(careful_bias_history, "Careful Bias", 1)
plt.legend()
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model = make_model()
model.load_weights(initial_weights)
baseline_history = model.fit(
train_features,
train_labels,
batch_size=BATCH_SIZE,
epochs=EPOCHS,
callbacks=[early_stopping],
validation_data=(val_features, val_labels))
def plot_metrics(history):
metrics = ['loss', 'prc', 'precision', 'recall']
for n, metric in enumerate(metrics):
name = metric.replace("_"," ").capitalize()
plt.subplot(2,2,n+1)
plt.plot(history.epoch, history.history[metric], color=colors[0], label='Train')
plt.plot(history.epoch, history.history['val_'+metric],
color=colors[0], linestyle="--", label='Val')
plt.xlabel('Epoch')
plt.ylabel(name)
if metric == 'loss':
plt.ylim([0, plt.ylim()[1]])
elif metric == 'auc':
plt.ylim([0.8,1])
else:
plt.ylim([0,1])
plt.legend()
plot_metrics(baseline_history)
train_predictions_baseline = model.predict(train_features, batch_size=BATCH_SIZE)
test_predictions_baseline = model.predict(test_features, batch_size=BATCH_SIZE)
def plot_cm(labels, predictions, p=0.5):
cm = confusion_matrix(labels, predictions > p)
plt.figure(figsize=(5,5))
sns.heatmap(cm, annot=True, fmt="d")
plt.title('Confusion matrix @{:.2f}'.format(p))
plt.ylabel('Actual label')
plt.xlabel('Predicted label')
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print('Legitimate Transactions Detected (True Negatives): ', cm[0][0])
print('Legitimate Transactions Incorrectly Detected (False Positives): ', cm[0][1])
print('Fraudulent Transactions Missed (False Negatives): ', cm[1][0])
print('Fraudulent Transactions Detected (True Positives): ', cm[1][1])
print('Total Fraudulent Transactions: ', np.sum(cm[1]))
#the accuracy using MSE is almost 1 and the loss is very small, only 0.138, comparing to the
training model, the loss is
#very close, so the model looks good
baseline_results = model.evaluate(test_features, test_labels,
batch_size=BATCH_SIZE, verbose=0)
for name, value in zip(model.metrics_names, baseline_results):
print(name, ': ', value)
print()
#plot_cm(test_labels, test_predictions_baseline)
result=model.trainable_variables
varaible_weights=result[1]
print(result[1])
print(model.trainable_variables) #return the Weights of the Model as shown below:
def plot_roc(name, labels, predictions, **kwargs):
fp, tp, _ = sklearn.metrics.roc_curve(labels, predictions)
plt.plot(100*fp, 100*tp, label=name, linewidth=2, **kwargs)
plt.xlabel('False positives [%]')
plt.ylabel('True positives [%]')
plt.xlim([-0.5,20])
plt.ylim([80,100.5])
plt.grid(True)
ax = plt.gca()
ax.set_aspect('equal')
# Scaling by total/2 helps keep the loss to a similar magnitude.
# The sum of the weights of all examples stays the same.
weight_for_0 = (1 / neg) * (total / 2.0)
weight_for_1 = (1 / pos) * (total / 2.0)
class_weight = {0: weight_for_0, 1: weight_for_1}
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print('Weight for class 0: {:.2f}'.format(weight_for_0))
print('Weight for class 1: {:.2f}'.format(weight_for_1))
resampled_steps_per_epoch = np.ceil(93.0*neg/BATCH_SIZE)
resampled_steps_per_epoch
for i, logits in enumerate(predictions):
class_idx = tf.argmax(logits).numpy()
p = tf.nn.sigmoid(logits)[class_idx]
name = class_names[class_idx]
print("Example {} prediction: {} ({:4.1f}%)".format(i, name, 100*p))
#the results shows that after training, there are 118 out of 184 proteins likely to be the X
molecule, it makes sense
#since our data is obtained from the corss-linking, most of the proteins should be targets anyway
#needs to find out a way to nail down top 10 target
general_recorded_weight=varaible_weights
Df1
data1=pd.DataFrame(df1).to_numpy()
Data1
weight_data=data1[:][:,-2]
ID=data1[:][:,-1]
print(ID)
location_weight=50*weight_data
len(location_weight)
Dt[184,:]
final=recorded_weight*dt[:,0:11]
print(final)
len(final)
gen_final=general_recorded_weight*dt[:,0:11]
print(gen_final)
len(gen_final)
resulta = [sum(element) for element in final]
final_prediction = location_weight+resulta
#print(final_prediction)
idx = (-final_prediction).argsort()[:12]
print(idx)
resultaa = [sum(element) for element in gen_final]
final_prediction = location_weight+resultaa
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#print(final_prediction)
idx1 = (-final_prediction).argsort()[:12]
print(idx)
new_idx=idx+1
print(new_idx)
#new_idx1=idx1+1
#print(new_idx1)
#G3GTC6 8 % Inactive serine protease 35,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC98051/
#https://www.uniprot.org/uniprot/G3GTC6
##G3H5I4 57 NPY
#G3HIP9. 40 ADAMTS12 Polyclonal antibody
##G3HTG1 128 anti-doc2b
#G3IL75. 150 Recombinant anti-collagen V antibody
#G3H0S3 174
#G3GSJ8 181
#G3IGQ2 26
#P0A9K9. 17
#G3H9U3 16
#G3IGQ2 27
#G3GWD3. 13
## is the repeated prediction that we used in machine learning, achieved using PCA

Appendix G: Cross-Linking Proteomics database
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